Sex as biological variable in Bronchopulmonary Dysplasia: Role of the Notch pathway
Sex as biological variable in Bronchopulmonary Dysplasia: Role of the Notch pathway
批准号:
10578253
负责人:
Krithika Lingappan
金额:
$20.06万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-23 至 2023-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Bronchopulmonary dysplasia (BPD) is a debilitating lung disease with long-term
consequences and is one of the most common causes for morbidity in premature
neonates. Postnatal exposure to high concentrations of oxygen (hyperoxia) contributes
to the development of BPD. Despite the well-established sex-specific differences in the
incidence of BPD and impaired lung function in males, the molecular mechanism(s)
behind these are not completely understood. Our laboratory has been focused on the
study of sex-specific differences in neonatal hyperoxic lung injury. Aberrant Notch
signaling contributes to the pathogenesis of many chronic lung diseases and Notch
activation is seen in lungs of human infants with BPD. The role of aberrant Notch
signaling in pulmonary dysangiogenesis in BPD has not been determined. Critically,
neonatal female mice have improved alveolarization and pulmonary vascular
development, which is associated with, decreased Notch pathway activation and
expression of the Notch ligand Dll4 compared to male littermates in a murine model of
BPD. The overall aim of this innovative proposal is to define the role of sex-specific
activation of Notch pathway in modulating pulmonary angiogenesis in neonatal
hyperoxic lung injury. We hypothesize that decreased Notch activation secondary to
lesser Dll4 expression preserves pulmonary angiogenesis in female neonates . The
above hypothesis will be tested by the following specific aims: Aim 1: Elucidate the
spatio-temporal role of endothelial DLL4 (Notch ligand) in modulating pulmonary
angiogenesis. Aim 2: Determine the role pulmonary endothelial Notch signaling in
modulating pulmonary angiogenesis in the developing lung exposed to hyperoxia. This
proposal will address knowledge gaps in the molecular mechanisms behind the sexual
divergent incidence of bronchopulmonary dysplasia and lay the foundation for future
sex-specific treatment strategies.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1165/rcmb.2021-0199ed
发表时间:
2021-08
期刊:
American journal of respiratory cell and molecular biology
影响因子:
6.4
作者:
[Lingappan K]
通讯作者:
Lingappan K
Role of Growth Differentiation Factor 15 in Lung Disease and Senescence: Potential Role Across the Lifespan.
生长分化因子15在肺部疾病和衰老中的作用:整个生命周期的潜在作用。
DOI:
10.3389/fmed.2020.594137
发表时间:
2020
期刊:
Frontiers in medicine
影响因子:
3.9
作者:
[Al-Mudares F, Reddick S, Ren J, Venkatesh A, Zhao C, Lingappan K]
通讯作者:
Lingappan K
Molecular insights using spatial transcriptomics of the distal lung in congenital diaphragmatic hernia.
使用先天性膈疝远端肺空间转录组学的分子见解。
DOI:
10.1152/ajplung.00154.2023
发表时间:
2023
期刊:
American journal of physiology. Lung cellular and molecular physiology
影响因子:
--
作者:
[Lingappan,Krithika, Olutoye2nd,OluyinkaO, Cantu,Abiud, CantuGutierrez,ManuelEliezer, Cortes-Santiago,Nahir, Hammond,JD, Gilley,Jamie, Quintero,JoselynRojas, Li,Hui, Polverino,Francesca, Gleghorn,JasonP, Keswani,SundeepG]
通讯作者:
Keswani,SundeepG
Leveraging multiomics and advanced mouse models to delineate mechanisms underlying sex‐specific differences in recovery and repair after neonatal hyperoxia exposure in the developing lung
-
批准号:10161856
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2020
-
负责人:Krithika Lingappan
-
依托单位:
Leveraging multiomics and advanced mouse models to delineate mechanisms underlying sex‐specific differences in recovery and repair after neonatal hyperoxia exposure in the developing lung
-
批准号:10619663
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2020
-
负责人:Krithika Lingappan
-
依托单位:
Leveraging multiomics and advanced mouse models to delineate mechanisms underlying sex‐specific differences in recovery and repair after neonatal hyperoxia exposure in the developing lung
-
批准号:10578175
-
项目类别:
-
资助金额:$41.37万
-
财政年份:2020
-
负责人:Krithika Lingappan
-
依托单位:
Mechanisms of sex differences in neonatal pulmonary oxygen toxicity
-
批准号:10447105
-
项目类别:
-
资助金额:$53.22万
-
财政年份:2019
-
负责人:Krithika Lingappan
-
依托单位:
Mechanisms of sex differences in neonatal pulmonary oxygen toxicity
-
批准号:10577223
-
项目类别:
-
资助金额:$53.8万
-
财政年份:2019
-
负责人:Krithika Lingappan
-
依托单位:
Mechanisms of sex differences in neonatal pulmonary oxygen toxicity
-
批准号:10641771
-
项目类别:
-
资助金额:$53.22万
-
财政年份:2019
-
负责人:Krithika Lingappan
-
依托单位:
Mechanisms of sex specific differences in neonatal hyperoxic lung injury
-
批准号:9052817
-
项目类别:
-
资助金额:$15.56万
-
财政年份:2015
-
负责人:Krithika Lingappan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
过表达CX45联合HCN4基因转染对起搏细胞自律性的影响
-
批准号:81170174
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:周亚峰
-
依托单位:
美洲大蠊药材养殖及加工过程中化学成分动态变化与生物活性的相关性研究
-
批准号:81060329
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:肖培云
-
依托单位:
慢病毒转染嵌合体HCN1+4拼接基因构建生物起搏细胞
-
批准号:81070139
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:杨向军
-
依托单位:
岭南瑶区几种瑶族抗肝炎植物药的化学成分及生物活性研究
-
批准号:20772047
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2007
-
负责人:岑颖洲
-
依托单位:
TB方法在有机和生物大分子体系计算研究中的应用
-
批准号:20773047
-
项目类别:面上项目
-
资助金额:26.0万元
-
批准年份:2007
-
负责人:吕文彩
-
依托单位:
天然生物材料的多尺度力学与仿生研究
-
批准号:10732050
-
项目类别:重点项目
-
资助金额:200.0万元
-
批准年份:2007
-
负责人:冯西桥
-
依托单位: